Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Celebrex was produced by Pfizer.

Lack of treatments depress EU bladder cancer market

Eli Lilly. II. Bexidem. Macrophage. IDM. II/III. Celebrex (celecoxib). COX inhibitor.

People, December, 2005

Vicki joins from Virgo Health PR and will be managing the Nicorette and Celebrex accounts.

Fast flourish

Pfizer's Celebrex - heart attack risk. Pfizer's Celebrex is used to treat acute pain for conditions such as arthritis. ... A recent study has linked Celebrex with a doubling of the risk of heart attacks.

Fall from grace

Figures for the quarter plummeted as sales for blockbuster arthritis drug, Celebrex, fell and cholesterol drug Lipitor also suffered from ailing sales. ... Demand for Celebrex, the global number one seller for arthritis pain, slumped when it was linked

TV ad spend squeeze

However, another more potent accelerant is likely to be the criticism levelled at the industry by regulators and the public, in particular following safety concerns over Vioxx and Celebrex, which had ... At the FDA's request, Pfizer pulled all consumer

[ Previous 5 results ] 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...